A yeast two-hybrid system for the screening and characterization of small-molecule inhibitors of protein-protein interactions identifies a novel putative Mdm2-binding site in p53

被引:29
作者
Wong, Jin Huei [1 ]
Alfatah, Mohammad [1 ]
Sin, Mei Fang [2 ]
Sim, Hong May [2 ]
Verma, Chandra S. [1 ,3 ,4 ]
Lane, David P. [5 ]
Arumugam, Prakash [1 ]
机构
[1] Bioinformat Inst, 30 Biopolis St,07-01, Singapore 138671, Singapore
[2] Natl Univ Singapore, Dept Pharm, 18 Sci Dr 4, Singapore 117543, Singapore
[3] Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr, Singapore 117543, Singapore
[4] Nanyang Technol Univ, Sch Biol Sci, 50 Nanyang Dr, Singapore 637551, Singapore
[5] P53 Lab, 8A Biomed Grove, Singapore 138648, Singapore
来源
BMC BIOLOGY | 2017年 / 15卷
关键词
Yeast two-hybrid assay; Protein-protein interaction inhibitors; p53-Mdm2; interaction; N-TERMINAL DOMAIN; SACCHAROMYCES-CEREVISIAE; ABC TRANSPORTERS; GENETIC SYSTEM; IN-VIVO; MDM2; PATHWAY; TRANSACTIVATION; DISCOVERY; NETWORK;
D O I
10.1186/s12915-017-0446-7
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Protein-protein interactions (PPIs) are fundamental to the growth and survival of cells and serve as excellent targets to develop inhibitors of biological processes such as host-pathogen interactions and cancer cell proliferation. However, isolation of PPI inhibitors is extremely challenging. While several in vitro assays to screen for PPI inhibitors are available, they are often expensive, cumbersome, and require large amounts of purified protein. In contrast, limited in vivo assays are available to screen for small-molecule inhibitors of PPI. Methods: We have engineered a yeast strain that is suitable for screening of small-molecule inhibitors of proteinprotein interaction using the Yeast 2-hybrid Assay. We have optimised and validated the assay using inhibitors of the p53-Mdm2 interaction and identified a hitherto unreported putative Mdm2-binding domain in p53. Results: We report a significantly improved and thoroughly validated yeast two-hybrid (Y2H) assay that can be used in a high throughput manner to screen for small-molecule PPI inhibitors. Using the p53-Mdm2 interaction to optimize the assay, we show that the p53-Mdm2 inhibitor nutlin-3 is a substrate for the yeast ATP-binding cassette (ABC) transporter Pdr5. By deleting nine ABC transporter-related genes, we generated a ABC9 Delta yeast strain that is highly permeable to small molecules. In the ABC9 Delta strain, p53-Mdm2 interaction inhibitors, like AMG232 and MI-773, completely inhibited the p53-Mdm2 interaction at nanomolar concentrations in the Y2H assay. In addition, we identified a conserved segment in the core DNA-binding domain of p53 that facilitates stable interaction with Mdm2 in yeast cells and in vitro. Conclusion: The Y2H assay can be utilized for high-throughput screening of small-molecule inhibitors of PPIs and to identify domains that stabilize PPIs.
引用
收藏
页数:17
相关论文
共 8 条
  • [1] A yeast two-hybrid system for the screening and characterization of small-molecule inhibitors of protein–protein interactions identifies a novel putative Mdm2-binding site in p53
    Jin Huei Wong
    Mohammad Alfatah
    Mei Fang Sin
    Hong May Sim
    Chandra S. Verma
    David P. Lane
    Prakash Arumugam
    BMC Biology, 15
  • [2] Recent Small-Molecule Inhibitors of the p53-MDM2 Protein-Protein Interaction
    Beloglazkina, Anastasia
    Zyk, Nikolai
    Majouga, Alexander
    Beloglazkina, Elena
    MOLECULES, 2020, 25 (05):
  • [3] Small-molecule modulation of p53 protein-protein interactions
    Kuusk, Ave
    Boyd, Helen
    Chen, Hongming
    Ottmann, Christian
    BIOLOGICAL CHEMISTRY, 2020, 401 (08) : 921 - 931
  • [4] Small-Molecule Inhibitors of the MDM2-p53 Protein-Protein Interaction (MDM2 Inhibitors) in Clinical Trials for Cancer Treatment
    Zhao, Yujun
    Aguilar, Angelo
    Bernard, Denzil
    Wang, Shaomeng
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (03) : 1038 - 1052
  • [5] Small-Molecule Inhibitors of the MDM2-p53 Protein-Protein Interaction to Reactivate p53 Function: A Novel Approach for Cancer Therapy
    Shangary, Sanjeev
    Wang, Shaomeng
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2009, 49 : 223 - 241
  • [6] The Fluorescent Two-Hybrid Assay to Screen for Protein-Protein Interaction Inhibitors in Live Cells Targeting the Interaction of p53 with Mdm2 and Mdm4
    Yurlova, Larisa
    Derks, Maarten
    Buchfellner, Andrea
    Hickson, Ian
    Janssen, Marc
    Morrison, Denise
    Stansfield, Ian
    Brown, Christopher J.
    Ghadessy, Farid J.
    Lane, David P.
    Rothbauer, Ulrich
    Zolghadr, Kourosh
    Krausz, Eberhard
    JOURNAL OF BIOMOLECULAR SCREENING, 2014, 19 (04) : 516 - 525
  • [7] Synthesis and biological evaluation of thio-benzodiazepines as novel small molecule inhibitors of the p53-MDM2 protein-protein interaction
    Zhuang, Chunlin
    Miao, Zhenyuan
    Zhu, Lingjian
    Zhang, Yongqiang
    Guo, Zizhao
    Yao, Jianzhong
    Dong, Guoqiang
    Wang, Shengzheng
    Liu, Yang
    Chen, Hai
    Sheng, Chunquan
    Zhang, Wannian
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2011, 46 (11) : 5654 - 5661
  • [8] Characterization and Optimization of a Novel Protein-Protein Interaction Biosensor High-Content Screening Assay to Identify Disruptors of the Interactions Between p53 and hDM2
    Dudgeon, Drew D.
    Shinde, Sunita N.
    Shun, Tong Ying
    Lazo, John S.
    Strock, Christopher J.
    Giuliano, Kenneth A.
    Taylor, D. Lansing
    Johnston, Patricia A.
    Johnston, Paul A.
    ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2010, 8 (04) : 437 - 458